The Serine/Threonine Kinase PAK4 Prevents Caspase Activation and Protects Cells from Apoptosis*

  1. Audrey Minden
  1. From the Department of Biological Sciences, Columbia University, New York, New York 10027

Abstract

The serine/threonine kinase PAK4 was identified first as an effector molecule for the Rho GTPase Cdc42. PAK4 differs from other members of the PAK family both in sequence and function. Previously we have shown that an important function of this kinase is to mediate the induction of filopodia in response to activated Cdc42. Studies with a constitutively active PAK4 mutant have shown that it also has a role in promoting anchorage-independent growth, an important hallmark of oncogenic transformation. Here we show that another function of PAK4 is to protect cells against apoptotic cell death. Expression of wild-type or constitutively active PAK4 delays the onset of apoptosis in response to tumor necrosis factor α stimulation, UV irradiation, and serum starvation. Consistent with an antiapoptotic function, expression of PAK4 leads to an increase in phosphorylation of the proapoptotic protein Bad and an inhibition of caspase activation.

  • Abbreviations:
    TNFα
    tumor necrosis factor α
    GST
    glutathione S-transferase
    CHX
    cycloheximide
    HA
    hemagglutinin
    PAGE
    polyacrylamide gel electrophoresis
    GBD
    GTPase binding domain
    PBS
    phosphate-buffered saline
    PARP
    Poly(ADP-ribose) polymerase
    • Received December 7, 2000.
    • Revision received January 22, 2001.
    Table of Contents

    This Article

    1. The Journal of Biological Chemistry 276, 14414-14419.
    1. All Versions of this Article:
      1. M011046200v1
      2. 276/17/14414 (most recent)

    Article Usage Stats

    Submit your work to JBC.

    You'll be in good company.